Form 4 for SLDB Solid Biosciences Inc.
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-02 · accession 0000899243-23-007270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-06 | 2023-03-02 | SLDB | Ganot Ilan | Dir | M - OptEx | — | +1,584 | 86.2K | +2% | — |
| D | 2023-03-06 | 2023-03-02 | SLDB | Ganot Ilan | Dir | M - OptEx | $0.00 | -1,584 | 4,749 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | M | A | 1,584 | — | 86,175 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) Represents 82,133 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. |
| 2 | Derivative | Restricted Stock Units | 2023-03-02 | M | D | 1,584 | $0.00 | 4,749 | D | — · — to — | 1,584 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full. |